FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126625430> ?p ?o ?g. }

• W3126625430 abstract "Systems vaccinology has been applied to detect signatures of human vaccine induced immunity but its ability, together with high definition in vivo clinical imaging is not established to predict vaccine reactogenicity. Within two European Commission funded high impact programs, BIOVACSAFE and ADITEC, we applied high resolution positron emission tomography/computed tomography (PET/CT) scanning using tissue-specific and non-specific radioligands together with transcriptomic analysis of muscle biopsies in a clinical model systematically and prospectively comparing vaccine-induced immune/inflammatory responses. 109 male participants received a single immunization with licensed preparations of either AS04-adjuvanted hepatitis B virus vaccine (AHBVV); MF59C-adjuvanted (ATIV) or unadjuvanted seasonal trivalent influenza vaccine (STIV); or alum-OMV-meningococcal B protein vaccine (4CMenB), followed by a PET/CT scan (n = 54) or an injection site muscle biopsy (n = 45). Characteristic kinetics was observed with a localized intramuscular focus associated with increased tissue glycolysis at the site of immunization detected by 18 F-fluorodeoxyglucose (FDG) PET/CT, peaking after 1–3 days and strongest and most prolonged after 4CMenB, which correlated with clinical experience. Draining lymph node activation peaked between days 3–5 and was most prominent after ATIV. Well defined uptake of the immune cell-binding radioligand 11 C-PBR28 was observed in muscle lesions and draining lymph nodes. Kinetics of muscle gene expression module upregulation reflected those seen previously in preclinical models with a very early (~6hrs) upregulation of monocyte-, TLR- and cytokine/chemokine-associated modules after AHBVV, in contrast to a response on day 3 after ATIV, which was bracketed by whole blood responses on day 1 as antigen presenting, inflammatory and innate immune cells trafficked to the site of immunization, and on day 5 associated with activated CD4+ T cells. These observations confirm the use of PET/CT, including potentially tissue-, cell-, or cytokine/chemokine-specific radioligands, is a safe and ethical quantitative technique to compare candidate vaccine formulations and could be safely combined with biopsy to guide efficient collection of samples for integrated whole blood and tissue systems vaccinology in small-scale but intensive human clinical models of immunization and to accelerate clinical development and optimisation of vaccine candidates, adjuvants, and formulations." @default.
• W3126625430 created "2021-02-15" @default.
• W3126625430 creator A5005716316 @default.
• W3126625430 creator A5007001229 @default.
• W3126625430 creator A5007167001 @default.
• W3126625430 creator A5016304975 @default.
• W3126625430 creator A5017078736 @default.
• W3126625430 creator A5019885357 @default.
• W3126625430 creator A5043707391 @default.
• W3126625430 creator A5044823136 @default.
• W3126625430 creator A5046960523 @default.
• W3126625430 creator A5048743323 @default.
• W3126625430 creator A5075073344 @default.
• W3126625430 creator A5076563457 @default.
• W3126625430 creator A5077503955 @default.
• W3126625430 creator A5079328759 @default.
• W3126625430 creator A5089375948 @default.
• W3126625430 date "2021-02-05" @default.
• W3126625430 modified "2023-09-25" @default.
• W3126625430 title "Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines" @default.
• W3126625430 cites W1570192772 @default.
• W3126625430 cites W1805709456 @default.
• W3126625430 cites W1969218538 @default.
• W3126625430 cites W1972495012 @default.
• W3126625430 cites W1979195886 @default.
• W3126625430 cites W1991378124 @default.
• W3126625430 cites W1993305977 @default.
• W3126625430 cites W1997090004 @default.
• W3126625430 cites W2002392006 @default.
• W3126625430 cites W2013493538 @default.
• W3126625430 cites W2029973105 @default.
• W3126625430 cites W2030547008 @default.
• W3126625430 cites W2043763882 @default.
• W3126625430 cites W2045347306 @default.
• W3126625430 cites W2055024864 @default.
• W3126625430 cites W2081282727 @default.
• W3126625430 cites W2092778039 @default.
• W3126625430 cites W2096729904 @default.
• W3126625430 cites W2096770070 @default.
• W3126625430 cites W2101243397 @default.
• W3126625430 cites W2120416394 @default.
• W3126625430 cites W2127897405 @default.
• W3126625430 cites W2144902263 @default.
• W3126625430 cites W2149954869 @default.
• W3126625430 cites W2150932450 @default.
• W3126625430 cites W2166727175 @default.
• W3126625430 cites W2276591160 @default.
• W3126625430 cites W2288758837 @default.
• W3126625430 cites W2471715561 @default.
• W3126625430 cites W2528211551 @default.
• W3126625430 cites W2560595878 @default.
• W3126625430 cites W2561772629 @default.
• W3126625430 cites W2580399783 @default.
• W3126625430 cites W2593166706 @default.
• W3126625430 cites W2612995849 @default.
• W3126625430 cites W2723706350 @default.
• W3126625430 cites W2765349383 @default.
• W3126625430 cites W2767110860 @default.
• W3126625430 cites W2781545991 @default.
• W3126625430 cites W2800772770 @default.
• W3126625430 cites W2802297021 @default.
• W3126625430 cites W2803559194 @default.
• W3126625430 cites W2806320832 @default.
• W3126625430 cites W2943197912 @default.
• W3126625430 cites W2945441307 @default.
• W3126625430 cites W2953042047 @default.
• W3126625430 cites W2957376989 @default.
• W3126625430 cites W2962522858 @default.
• W3126625430 cites W2993614348 @default.
• W3126625430 cites W2997630903 @default.
• W3126625430 cites W3013152612 @default.
• W3126625430 cites W3023989676 @default.
• W3126625430 cites W3082694457 @default.
• W3126625430 cites W367439898 @default.
• W3126625430 doi "https://doi.org/10.3389/fimmu.2020.613496" @default.
• W3126625430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7893084" @default.
• W3126625430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33613536" @default.
• W3126625430 hasPublicationYear "2021" @default.
• W3126625430 type Work @default.
• W3126625430 sameAs 3126625430 @default.
• W3126625430 citedByCount "6" @default.
• W3126625430 countsByYear W31266254302021 @default.
• W3126625430 countsByYear W31266254302022 @default.
• W3126625430 countsByYear W31266254302023 @default.
• W3126625430 crossrefType "journal-article" @default.
• W3126625430 hasAuthorship W3126625430A5005716316 @default.
• W3126625430 hasAuthorship W3126625430A5007001229 @default.
• W3126625430 hasAuthorship W3126625430A5007167001 @default.
• W3126625430 hasAuthorship W3126625430A5016304975 @default.
• W3126625430 hasAuthorship W3126625430A5017078736 @default.
• W3126625430 hasAuthorship W3126625430A5019885357 @default.
• W3126625430 hasAuthorship W3126625430A5043707391 @default.
• W3126625430 hasAuthorship W3126625430A5044823136 @default.
• W3126625430 hasAuthorship W3126625430A5046960523 @default.
• W3126625430 hasAuthorship W3126625430A5048743323 @default.
• W3126625430 hasAuthorship W3126625430A5075073344 @default.
• W3126625430 hasAuthorship W3126625430A5076563457 @default.
• W3126625430 hasAuthorship W3126625430A5077503955 @default.
• W3126625430 hasAuthorship W3126625430A5079328759 @default.
• W3126625430 hasAuthorship W3126625430A5089375948 @default.

• next